SCHEMBL4991398

SCHEMBL4991398

CNC[C@H](C)N(C(=O)OC(C)(C)C)C1CCC(O[Si](C)(C)C(C)(C)C)CC1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPM1D O15297 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4991394 1.00 PPM1D (0.30) PPM1D
SCHEMBL4973308 0.90 PPM1D (0.33) PPM1D
SCHEMBL4974713 0.87 PPM1D (0.31) PPM1D
SCHEMBL4974716 0.87 PPM1D (0.31) PPM1D
SCHEMBL4970498 0.81 GAA (0.34)
SCHEMBL4969953 0.81 GAA (0.34)
SCHEMBL4972581 0.80 GAA (0.36)
SCHEMBL4972576 0.80 GAA (0.36)
SCHEMBL4971462 0.80 GAA (0.36)
SCHEMBL4971467 0.80 GAA (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed